LAB reported year-end net profit of $144.04 million

January 5, 2023


The Limners and Bards Limited (LAB), for the year ended October 31, 2022, reported 10% increase in revenues to $1.34 billion (2021: $1.23 billion). For the quarter, revenues declined 18% to $233.47 million (2021: $285.19 million).

Cost of operating revenue increased 2% to $870.48 million (2021: $851.40 million). Consequently, gross profit increased by 26% closing at $474.31 million (2021: $375.81 million). For the quarter, gross profit increased 4% to $94.34 million (2021: $91.01 million).

Profit on disposal of assets amounted to $930,934 (2021: nil). For the quarter, loss on disposal of assets amounted to $462,500 (2021: nil)

Total operating expenses increased 34% to $321.58 million (2021: $239.88 million). For the quarter, total operating expenses increased 14% to 93.71 million (2021: $82.25 million). Of the year-end total expenses:

  • Administrative expenses increased 35% to $315.94 million (2021: $233.52 million)
  • Selling and distribution costs declined 72% to $1.04 million (2021: $3.75 million).
  • Impairment losses on the financial assets increased 76% to $4.60 million (2021: $2.61 million).

Consequently, profit before net finance cost and taxation increased 13% to $153.66 million (2021: $135.93 million).

Net finance cost amounted to $10.53 million (2021: income of $17.50 million). Loss in value of investments classified as FVTPL amounted to $69,841 (2021: gain of $69,841).

Profit before taxation declined 7% to $143.06 million (2021: $153.50 million). There was a tax credit of $978,813 (2021: $2.05 million).

As such, net profit for the year end declined 7% to $144.04 million (2021: $155.55 million). For the quarter, net loss amounted to $264,639 (2021: profit of $13.37 million).

Earnings per share (EPS) for the year end amounted to $0.15 (2021: $0.16). For the quarter, LPS amounted to $0.0003 (2021: EPS of $0.014). The number of shares used in our calculations is 945,690,252 units. Notably, LAB’s stock price closed at $2.43 on January 4, 2023 with a corresponding P/E ratio of 15.95 times.

Balance Sheet Highlights:

As at October 31, 2022, the Company reported total assets of $892.08 million (2021: $806.23 million), an 11% increase year over year. This was primarily because of the 59% increase in ‘Accounts Receivable’ which closed at $353.06 (2021: $222.23 million).

Shareholders’ Equity as at October 31, 2022 was $574.33 million (2021: $515.72 million). This resulted in a book value per share of $0.61 (2021: $0.55).



Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer(s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view(s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.